These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [mRNA-transfected dendritic cells: a promising strategy in immunotherapy].
    Author: Maisnier-Patin K, Crabé S, Breton G, Dupuy FP, Yassine-Diab B, Sékaly RP.
    Journal: Med Sci (Paris); 2007 Mar; 23(3):279-84. PubMed ID: 17349289.
    Abstract:
    Dendritic cells play a central role in the initiation of the immune response as they are the only antigen-presenting cells able to prime naive T cells. This makes the dendritic cells the vector of choice to use as a cell-based vaccine in immunotherapy. Although there are several strategies to deliver antigen to dendritic cells, the ones transfected with mRNA coding for tumor or viral antigens are able to induce potent antigen specific T-cell responses directed against multiple epitopes. In this review, we report several advances made in the field of anti-tumoral and anti-HIV immunotherapy using mRNA-transfected dendritic cells-based approaches.
    [Abstract] [Full Text] [Related] [New Search]